Galp Energia Nom (0B67)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 22.86 |
|---|---|
| 52-week range | 13.96 – 23.18 |
| Return, 1 month / 3 months | +2.7% / +12.5% |
| Return, 1 year / 3 years | +40.4% / +74.7% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 32.2% |
| Worst drawdown (1 year) | -24.1% |
| Average daily value traded | 9.54M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Galp Energia is a Portuguese energy company based in Lisbon. It explores for and produces oil and natural gas, refines crude oil into fuels and other petroleum products, and distributes natural gas. The company also generates and sells electricity and serves motorists through its fuel retail network. Its customers include industrial and commercial businesses, energy traders and households, mainly in Portugal and Spain, with exploration and production activity in several other countries.
The shares are listed on the London Exchange in UK under the code 0B67, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Galp Energia Nom (0B67) trades on the London Exchange in UK. It last closed at EUR 22.86 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 359 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.4% and over the last three months it rose 12.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.1% | ||
| From 52-week high | -0.5% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.5% | ||
| 6-month return | 21.3% | ||
| 12-month return, skipping the last month | 36.8% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.1% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 9.54M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +2.7% |
| 3 months | +12.5% |
| 6 months | +21.3% |
| 1 year | +40.4% |
| 3 years | +74.7% |
| 5 years | +184.1% |
Signals
| 50-day / 200-day average | 21.85 / 19.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | EUR 0.3500 |
| 19 May 2026 | EUR 0.3300 |
| 14 Aug 2025 | EUR 0.3100 |
| 23 May 2025 | EUR 0.3400 |
| 15 Aug 2024 | EUR 0.2800 |
| 29 May 2024 | EUR 0.2700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.